► Click here to download the original poster (PDF)
L. TALON1, V. FOURNEYRON1, M. TARDIEU1, A. TRAPANI1, T. SINEGRE1 and A. LEBRETON1,2
1 Hématologie biologique, CHU Clermont Ferrand, Clermont Ferrand, France
2 Unité de nutrition humaine, UMR 1019, INRAE Université d’Auvergne
Dilute Russell’s viper venom time (dRVVT) is one of the recommended assays for lupus anticoagulant (LA) detection. However, reagents variability affects diagnostic efficacy in LA testing and it is not clear whether all dRVVT reagents may be considered equivalent1.
The objective of this study was to evaluate the analytical performances of a new formulation DVVtest/DVVconfirm (BioMedica Diagnostics) performed with the Yumizen G800 analyzer (HORIBA Medical) and to compare it with a currently available dRVVT assay performed on a STAR Max analyzer (Stago).
Within-run and between-run imprecision were evaluated using low and high quality control plasma samples (LAtrol Normal and Abnormal, HORIBA Medical).
LA was considered positive if the screening test (DVVtest) and the LA ratio (DVVtest/DVVconfirm) were positive (threshold provided by the manufacturers).
Within-run and between-run coefficients of variation were consistent with manufacturer’s data (Table 1).
For DVVtest/DVVconfirm assay performed on the Yumizen G800 analyzer, sensitivity, specificity and negative predictive value were of 90%, 97% and 97.8%, respectively (Table 2).
Among the 39 patients who were LA-negative with Stago dRVV reagents, 6 were found positive with DVVtest/DVVconfirm including 2 patients with systemic lupus erythematosus and 2 patients with positive anticardiolipin and anti-beta 2 glycoprotein I antibodies, raising the question of the sensitivity/specificity of these assays.
The analytical performances of DVVtest and DVVconfirm reagents make it suitable for LA detection in clinical laboratories.
1 Depreter B, Devreese KMJ. Dilute Russell’s viper venom time reagents in lupus anticoagulant testing: a well-considered choice. Clinical Chemistry and Laboratory Medicine (CCLM) 2017;55:91-101.
Sie haben Fragen oder Wünsche? Nutzen Sie dieses Formular, um mit unseren Spezialisten in Kontakt zu treten.